Objectives: We aimed to assess the association between metabolic syndrome (MS) and hepatitis B/C virus infection using a large population-based study. Design and methods: A population-based cross-sectional study design was adopted with a total of 53 528 subjects being enrolled from the integrated multiple diseases screening program in Keelung, Taiwan. Evidence of past hepatitis B/C infection, acquired during childhood or as a young adult, was identified during the two-stage liver cancer screening part of the process. Information on biochemical markers and anthropometric measures related to MS, such as fasting blood sugar, triglyceride and high-density lipoprotein (HDL), abdominal circumference and blood pressure (BP), were collected routinely while screening for hypertension, type 2 diabetes, and hyperlipidemia. Logistic regression was used to estimate odds ratios and related 95% confidence intervals for the associations between MS and hepatitis B/C infection. Results: High blood pressure (SBPX135 mmHg or DBPX85 mmHg) (adjusted odd ratio: 0.89 (0.83-0.94)) and high triglyceride (X150 mg/dl) (adjusted odds ratio: 0.65 (0.60-0.69)) were, after adjusting for gender and age, inversely associated with being HBsAg positive (Po0.05). The likelihood of developing MS was lower in the HBsAg positive than the HBsAg negative (adjusted odds ratio: 0.84 (0.76-0.93)). A positive association between being anti-HCV positive and having low serum HDL (male o40 mg/dl, female o50 mg/dl) was also noted (adjusted odds ratio: 1.61 (1.37-1.88) after controlling for gender and age). High triglyceride was inversely associated with being anti-HCV positive (adjusted odds ratio: 0.63 (0.55-0.71). Conclusions: There is an inverse association between MS and hepatitis B virus infection whereas the association was heterogeneous for HCV infection with a positive association with abnormal serum HDL but an inverse association with hypertriglyceridemia.
Introduction
The association between hepatitis B and C infections and metabolic syndrome (MS) has become the subject of interest over the past decade, particularly in areas with high prevalence rate of both. The liver plays a crucial role in the pathophysiology of the MS 1 and viral hepatitis has been reported to be detrimental to hepatocyctes 2, 3 so the relationship between individual components of MS and hepatitis B/C infection, two established risk factors for hepatocelluar carcinoma, should now be assessed. A previous study demonstrated a significant association between high-density lipoprotein (HDL) and asymptomatic chronic HBV infection. 4 A recent molecular study also found that HDL plays an active role in facilitating hepatitis C virus entry through the Scavenger receptor (class B type 1). 5 In addition, the results from previous studies investigating the relationship between hepatitis B infection and type 2 diabetes are inconsistent. Three studies reported a positive association between the two, [6] [7] [8] two found no association, 9, 10 and one found an inverse association. 11 Inconsistent results have also been reported about the association between hepatitis C infection and type 2 diabetes. [12] [13] [14] [15] [16] [17] [18] [19] These inconsistencies may be due to small sample sizes and selected patients from hospital, so a large population-based study is again desirable. The assessment of these relationships are particularly important for Taiwanese subjects aged over 30 years because this cohort did not receive hepatitis B vaccination and now has a 15-20% prevalence of hepatitis B infection. Since hepatitis B or C infection in Taiwan is often acquired during childhood or young adulthood, 20, 21 whereas the individual components of MS develop later in life, a population-based study design is required to elucidate the association between hepatitis B or C virus infection and MS. Normally, information on hepatitis virus infection and MS is difficult to obtain in a single study. However, the recently instigated multiple screening program in Keelung provided us with the opportunity to contemporaneously measure the hepatitis infection status (one of high-risk group criteria for liver cancer screening, see below), and MS in an adults. 22 The aim of this study is therefore to assess the association between MS and hepatitis B or C infection using data from a large populationbased community screening study.
Methods
Population and study design Our data comes from the Keelung Community-based Integrated Screening (KCIS) program in Taiwan. The target population consisted of 53 528 subjects who were aged between 30 and 79 years between 1 January 1999 and 31 December 2002. Details on the design, implementation, and preliminary results from this program have been described in full elsewhere. 22 In brief, the KCIS used the existing Pap smear screening program as the basis for integrating other disease screening activities to create a unified system. Five neoplastic diseases (cervical neoplasm, breast cancer, colorectal neoplasm, liver cancer, and oral neoplasm) and three non-neoplastic chronic diseases (Type 2 diabetes, hypertension, and hyperlipidemia) were screened for in this program. Biochemical variables appertaining to the three non-neoplastic chronic diseases enabled us to define MS in accordance with ATPIII criteria (see below). In line with our liver cancer screening program we used a two-stage approach. At the first stage, high-risk individuals were identified as those who were HBsAg or Anti-HCV positive, those with AST level greater than 60 mg/dl, ALT level greater than 60 mg/dl, and a-fetoprotein level greater than 60 mg/dl. Subjects meeting these criteria were referred for sonography.
Definition of MS
The information collected in the KCIS project included the major risk factors associated with MS. This enabled us to identify those with MS using the following criteria: central obesity (defined, using the adjustment for oriental countries, as men with waist circumference higher than 90 cm or women with waist circumference higher than 80 cm), triglyceride (TG) X150 mg/dl, HDL o40 mg/dl for men and HDL o50 mg/dl for women, systolic blood pressure (SBP) X130 mmHg or diastolic blood pressure (DBP) X85 mmHg, and fasting glucose X110 mg/dl. Information regarding medical treatment and metabolic control of pre-existing cases of DM or hypertension was obtained via self-administered questionnaires. Those with levels of fasting blood sugar greater than 110 mg/dl and pre-existing cases of DM were defined as having impaired serum glucose. Those with levels of systolic BP greater than 135 mmHg and/or diastolic BP greater than 85 mmHg, and pre-existing cases of hypertension, were defined as having high BP. Mass screening for hypertension and total cholesterol (TC), TG, and HDL were also conducted.
Serum viral markers and biochemistry
We checked HBsAg and anti-HCV status in attendants of the KCIS program. HBsAg and anti-HBs were detected using radioimmunoassay kits (Abbott Laboratories, Chicago, IL, USA). Anti-HCV was detected using a third-generation enzyme immunoassay (Abbott Laboratories). Fasting plasma glucose, serum TC, TG, and HDL levels were measured using standard laboratory tests. (Daiichi Pure Chemicals Co. Ltd, Tokyo, Japan)
Statistical analysis
Logistic regression model was used to assess the association between hepatitis infection status and biochemical markers related to MS with or without for age and gender. Odds ratios and their 95% confidence intervals were also calculated. Statistical significance throughout was set at 5%.
Results
Of the 53 528 subjects participating in the KCIS program between 1999 and 2002, a total of 5995 (12. 6%) individuals were found to be HBsAg ( þ ) and 1792 (3.8%) anti-HCV ( þ ). Table 1 and Table 2 show the carrier rates of HBsAg and anti-HCV by individual components of MS. All individual components of MS were inversely associated with HBsAg ( þ ). The negative associations between high BP and high TG and HBsAg ( þ ) still remained statistically significant after adjustment for gender and age (Po0.05). There were no statistically significant associations with the three other components (fasting glucose, HDL, and abdominal obesity). After adjustment for age and gender those who were HBsAg ( þ ) were less likely to have concomitant MS than those who were HBsAg (À) (adjusted odds ratio: 0.84, 95% CI: 0.76B0.93).
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Positive associations were noted between hepatitis C infection and high serum fasting glucose, high BP, low HDL, and abdominal obesity, respectively (Po0.05). After controlling for gender and age, the positive association between reduced HDL level (HDL less than 40 mg/dl) and anti-HCV ( þ ) remained statistically significant (Po0.05) Metabolic syndrome and hepatitis B, C C-F Jan et al (adjusted odds ratio: 1.61 (1.37-1.88)). However, high TG was inversely associated with anti-HCV ( þ ) even after adjustment for gender and age (Po0.05).
Discussion
In this large population-based study, we found the inverse association between HBV infection and MS. The associations of HCV infection with components of the MS are more heterogeneous, but a trend towards an association with MS can indeed be seen. We have corroborated a series of associations between individual components of MS and hepatitis B/C infection. After controlling for age and gender, reduced HDL and high TG level were shown to be strongly related to hepatitis C infection and elevated BP and higher TG level inversely related to hepatitis B infection. Interpretation of the relationships between individual components of MS and HBV and HCV infection is delineated as follows.
Dyslipidaemia
Lipids have long been suspected to play a crucial role in the host immune response to infections. 23, 24 Our findings, that reduced HDL level was positively associated with hepatitis C infection and inversely associated with hepatitis B infection (albeit nonsignificantly), have two possible explanations. First, this may be due to proinflammatory cytokines, such as interleukin-6 and tumor necrosis factor (TNF) that are well documented to be positively associated with MS. By relating blood profiles to circulating cytokines in patients with chronic viral hepatitis due to HBV or HCV infection, Fabris et al. 25 found that the differences between HBV and HCV in terms of the mechanism of liver damage and viral clearance manifested by the levels of circulating cytokines were related to differences in blood lipids profiles such as HDL. In patients with HCV infection, lower levels of HDL were associated with higher levels of interleukin-6 (Po0.01). In patients with HBV infection, the direction was inverse but not statistically significant. These findings are consistent with our positive association for HCV infection and inverse association for HBV infection in relation to reduced HDL. Note that our findings on lower triglyceride, higher LDL, higher TC, higher HDL in HBV infection compared with HCV infection were also in agreement with previous studies, which adds to the credence of this postulate. Secondly, it may be that, as suggested by recent research, HDL and its physiologically relevant receptor, Scavenger Receptor Class B Type 1 (SR-BI), play an active role in facilitating HCV entry. 5 However, no studies to date have reported similar findings for HBV infection. High serum TG levels have also been reported in subjects without hepatitis B/C infection. Iannnello et al. 26 found that both lean and obese patients affected by chronic active B or C hepatitis presented with a marked TG decrease. 27 Similarly, HCV antibody-positive hepatitis was also shown to be associated with low levels of TG in a Japanese and Taiwanese studies. 4, 28 A previous study showed that hypertriglyceridemia, one of the abnormalities present in liver steatosis, is associated with elevation of ALT in patients without HBV or HCV infection. 29 This is in agreement with our study. Table 3 shows the odds ratios for hypertriglyceridemia and elevated serum ALT (X60 IU/l) in the absence/presence of HBV or HCV infection. Hypertriglyecridemia evidently plays a more important role in elevating serum ALT among subjects free of the hepatitis B/C virus than in those infected. Subjects who were HCV negative and had a high level of TG were 2.66 (95% CI: 2.52-2.82) times as likely to have an elevated ALT level as those whose TG level was not elevated. There was no equivalent effect in subjects with HCV infection.
Hyperglycemia and type 2 diabetes
As one component of MS is hyperglycemia (serum fasting glucoseX110 mg/dl), it is very interesting to assess its association, and that of type 2 diabetes, with hepatitis B/C virus infection. Regarding hepatitis C infection, a positive association was found but it was not statistically significant after controlling for age and gender (Table 2) . A non-significant association was also noted when type 2 diabetes was used as outcome (P ¼ 0.54). These findings confirm that hyperglycemia or type 2 diabetes is inversely associated with HBV infection but not related to HCV infection (Table 3 ).
Blood pressure
Elevated BP was inversely associated with MS for HBV infection after adjust for age and gender. Whether these inverse associations are merely a reflection of hyper triglyceride or LDL, both of which were inversely association with MS in HBV infection, or related to lean body size that is also inversely associated with MS in HBV infections is a matter worthy of further investigation.
Obesity
In our study, increased waist circumference was not associated with MS in those infected with either HBV or We have used a large population-based study to corroborate the previously reported associations between individual components of MS, and HBV, or HCV infection, as mentioned above. In addition to benefiting from a larger sample size, our results have several significant clinical implications. As hepatitis C infection appears to be associated with reduced serum HDL levels, which is an established independent risk factor for coronary artery disease, the HCV-positive group could well be at increased risk of developing cardiovascular disease. This issue should therefore be assessed in a future study by comparing the incidence of CVD in subjects with HCV infection with those HCV negative. Risk factors related to MS were more likely to be found in subjects free of the hepatitis B virus. This suggests that in the absence of viral hepatitis, raised liver function is closely associated with high serum triglyceride. In addition, a lower serum TG level, as frequently seen in subjects free of hepatitis B infection, may also suggest that hepatic triglyceride accumulation, caused by hepatitis B X protein, originated from the hepatitis B genome. 30 It may have a strong influence on the secretion of apoB, which is associated with the development of liver cancer.
In conclusion, we have elucidated the relationship between MS and hepatitis B and C infection, in an area with a high prevalence of both, using a population-based study. The results corroborated an inverse associations between MS and hepatitis B infection whereas the association was heterogeneous for HCV infection with a positive association with HDL and an inverse association with TG. Metabolic syndrome and hepatitis B, C C-F Jan et al
